Australian women are silently managing digestive health challenges

New research from Iberogast highlights the impact of unmanaged digestive symptoms on the daily lives of Australian women and the need for greater awareness, support and access to evidence-based care.

Digestive health conditions such as Irritable Bowel Syndrome (IBS) affect women at disproportionately higher rates than men and can have a significant impact on everyday life. New research commissioned by Iberogast, a Bayer-owned brand, reveals that many Australian women are quietly managing symptoms including bloating, gas, stomach pain and constipation, often altering their routines, behaviours and lifestyle choices to avoid embarrassment.

The findings show that digestive symptoms can influence where women go at work, how they manage their time at home, and even what they choose to wear. More than three-quarters (77%) of women who experience digestive issues say their gut health affects their clothing choices, while many report taking steps to conceal symptoms from colleagues, friends and family members.

Despite the prevalence of digestive discomfort, conversations about gut health remain limited. Less than one-third (27%) of women experiencing digestive issues feel comfortable discussing their symptoms with close friends or family. At the same time, many women continue to live with persistent symptoms, including bloating (64%), gas (59%), stomach pain (54%) and constipation (52%).

The research also highlights ongoing challenges in accessing support and diagnosis. More than one-third (38%) of women experiencing digestive issues have not sought medical advice because they did not believe their symptoms were serious enough, while 24% report having their symptoms initially attributed to stress, anxiety or normal PMS symptoms. In the absence of professional guidance, 38% turn to social media, podcasts or internet searches to help understand and manage their symptoms.

Jodie Lynch, Consumer Health Lead, Bayer Australia, said the findings reveal the often-hidden burden digestive issues can place on women's daily lives.

"Our research shows that many Australian women are making daily adjustments to manage digestive symptoms, often in silence. By encouraging more open conversations about gut health and promoting access to evidence-based support, we hope to help women feel more confident seeking the care they need."

Dr. Ayesha Shah, Consultant Gastroenterologist at the Princess Alexandra Hospital in Brisbane, said women experiencing ongoing digestive symptoms should not feel they need to manage the condition alone.

"Living with bloating, pain or unpredictable bowel habits is not something women simply have to accept. In addition to speaking with a GP, community pharmacists can provide evidence-based advice, help manage symptoms and recommend when further medical care may be required."

The findings highlight the importance of reducing stigma around digestive health and improving access to trusted, evidence-based information and support. By seeking professional guidance and discussing symptoms openly, women can take steps toward better managing digestive health and improving quality of life.

About the Survey: Bayer commissioned consumer research company Pureprofile to survey 1,013 Australian women who experience chronic or frequent digestive health issues on their attitudes, experiences and behaviours around digestive and gut health.

About Iberogast: Iberogast® offers clinically proven herbal solutions that are scientifically designed to help relieve 9 digestive symptoms: upper abdominal pain, early satiety, bloating, heartburn, loss of appetite, upset stomach, nausea, abdominal cramps and vomiting. Designed for convenience and regular use, Iberogast offers whole-gut support in one solution, so consumers don’t have to wait until symptoms worsen or manage multiple products. For more information visit https://www.iberogast.com.au/